Biotechnology Jobs

GSK · Waltham, United States · US$340,500 – US$567,500 pa

Leads global development of a cancer vaccine asset from late-stage transition through approval and launch, acting as single point of accountability across major markets. Builds and directs a matrix Medicine Development Team spanning clinical development, immunology/biomarkers, manufacturing, regulatory, safety, medical affairs and commercial, and represents the asset to senior governance boards.

GSK · Stevenage · US$340,500 – US$567,500 pa

Leads global development of a cancer vaccine asset from late-stage transition through approval and launch, acting as single point of accountability. Builds and leads a matrix Medicine Development Team spanning clinical development, immunology, manufacturing, regulatory, safety, medical affairs and commercial, and sets the asset strategy within GSK's oncology R&D portfolio.

CSL · Waltham, United States

Leads an integrated quality assurance organisation covering Good Clinical Practice and Good Pharmacovigilance Practice, reporting to the Head of Global R&D Quality. Sets strategy, operating model and standards for risk-based QA oversight from trial design through close-out, including inspection readiness, CAPAs and clinical safety interfaces such as SAE reconciliation and expedited reporting. Hybrid role with global team leadership and international travel.

CSL · Opfikon, Switzerland

Leads strategic sourcing and evaluation of late-stage external clinical assets in Immunology, from Phase 2 through marketed drugs. Sits on the Therapy Area Leadership Team, co-leads New Product Opportunity reviews, engages external KOLs and investigators, and drives cross-functional due diligence with BD to close deals.

Recursion · Remote Opportunity - United States · US$261,800 – US$346,060 pa

Lead clinical pharmacology and pharmacometrics strategy across a portfolio of rare disease and oncology programs, serving as the clinical pharmacology lead and regulatory representative. Oversee modeling and simulation (population PK, PK-PD, exposure-response) and provide pharmacology input on Phase 1-3 study designs. Work cross-functionally with clinical, translational and discovery teams in an end-to-end drug development environment.

Autolus · US - East Coast

Leads identification, evaluation and execution of strategic partnerships, licensing, M&A and co-development deals, from sourcing through due diligence, structuring and closing. Represents the company to biotech, pharma and academic partners, monitors competitive and market dynamics, and advises executive leadership on external innovation strategy post-launch.

Isomorphic Labs · Cambridge, United States

Lead end-to-end clinical trial material planning, vendor management, packaging, labeling, inventory and global distribution for an AI-first drug discovery company. Act as the clinical supply authority within a lean Pharmaceutical Sciences & CMC team, building scalable systems and vendor networks while partnering closely with Clinical Operations and CROs.

Vertex Pharmaceuticals · London

Oversees cell and gene therapy Contract Manufacturing Organizations as the primary on-site point of contact, providing operational, quality and technical oversight of cGMP commercial supply. Acts as a Person-in-Plant and SME within the Virtual Plant Team, managing deviations, change controls, batch data and supplier governance, with up to 50% travel and shift coverage for critical process steps.

Autolus · Stevenage

Accountable for onboarding and ongoing performance management of apheresis and treatment centres supporting clinical and commercial CAR T-cell therapies across the UK and Rest of World. Serves as the technical operations single point of contact, conducting site assessments, training centre staff, supporting quality systems and deviations, and managing process change rollouts. Involves up to 50% travel and possible management of contract employees.

SRG · Darlington · £65,000 – £85,000 pa

Lead multidisciplinary operational teams across two sites, covering operations, engineering, facilities and site services. Drive continuous improvement, GMP and H&S compliance, facilities management, budgets and capital projects supporting biologics, RNA and medicines manufacturing. Senior leadership role shaping facility strategy and operational capability.

Moderna · London

Lead CMC regulatory strategy for UK-manufactured and UK-licensed mRNA products across development, registration and post-approval lifecycle. Act as primary point of contact with the MHRA, oversee submissions and manufacturing change assessments, and shape global regulatory approaches across cross-functional matrix teams.

Evotec · Abingdon

Owns Evotec's in silico therapeutics design capability, uniting computational chemistry, generative and modality design (small molecules, peptides, protein engineering, degraders, molecular glues) and predictive ADMET/safety under one mandate. A newly created unit within the In Silico & AI group with an explicit build mandate: set technical vision, grow a multi-site team, and industrialise repeatable, benchmarked methods across partner programmes.

Evotec · Abingdon

Leads Evotec's consolidated AI Accelerator, owning machine learning, generative and agentic AI, and therapeutic hypothesis groups. Sets the AI vision and roadmap, makes build/buy/partner decisions for the AI stack, and turns proprietary multi-omics and experimental data into predictive models and reusable IP. Acts as the senior external technical voice for AI in drug discovery.

Relation Therapeutics · London

Lead clinical pharmacology and pharmacometrics across a growing drug discovery portfolio, serving as the quantitative lead on cross-functional project teams. Apply MIDD, PBPK, population PK/PD and QSP modelling to translate nonclinical data into human dosing and trial design, spanning small molecules, biologics and novel platforms. Also manages CRO partnerships and authors regulatory submissions.